author-photo

Heidi Dipietro

Harvard University

5

Papers

148

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma

2019 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (106)
A Phase II Study of the Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone (RVD) Combination Therapy for Patients with Newly Diagnosed Multiple Myeloma: Promising Activity and Manageable Toxicity, Including in High Risk Disease

2018 Blood
Show All
- Source
- Cite
- Save
Citations (0)
An open-label, single arm, phase IIa study of bortezomib, lenalidomide, dexamethasone, and elotuzumab in newly diagnosed multiple myeloma.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (15)
A Pilot Study of Eltrombopag Plus G-CSF for Human CD34+ Cell Mobilization in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplant

2016 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Safety Data from a First-in-Human Phase 1 Trial of NKG2D Chimeric Antigen Receptor-T Cells in AML/MDS and Multiple Myeloma

2016 Blood
Show All
- Source
- Cite
- Save
Citations (27)